Published in Cancer Imaging on April 15, 2013
Malignant and Metastatic Pheochromocytoma: Case Report and Review of the Literature. Urol Case Rep (2014) 0.81
Nuclear imaging to characterize adrenal tumors: Comparison with MRI. World J Radiol (2014) 0.77
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab (2009) 2.51
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer (2007) 2.10
Pheochromocytoma: current approaches and future directions. Oncologist (2008) 2.05
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer (2008) 1.54
Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab (2007) 1.51
Monitoring cancer treatment with PET/CT: does it make a difference? J Nucl Med (2007) 1.45
Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach. Cancer Treat Rev (2010) 1.42
Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med (1988) 1.37
Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med (1990) 1.22
The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer (2007) 1.19
Scintigraphic imaging of body neuroendocrine tumors. Radiographics (2007) 1.17
The role of nuclear medicine in monitoring treatment in skeletal malignancy. Semin Nucl Med (2001) 1.12
Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res (1987) 1.10
Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis. J Nucl Med (1994) 0.85
Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma. Aust N Z J Surg (1999) 0.81
Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio. Ann Nucl Med (2012) 0.79
Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma. Eur J Nucl Med Mol Imaging (2011) 0.79
Role of nuclear medicine in chemotherapy of malignant lesions. Semin Nucl Med (1985) 0.79
White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging. Eur J Nucl Med Mol Imaging (2007) 4.75
Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett (2005) 3.65
Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease. Eur J Nucl Med Mol Imaging (2012) 2.17
White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging. Eur Radiol (2007) 2.05
Pitfalls in statistical methods. J Nucl Cardiol (2012) 2.00
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine (2013) 1.72
Labelling of cells with quantum dots. Nanotechnology (2005) 1.57
Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography. J Nucl Cardiol (2011) 1.54
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique. J Nucl Cardiol (2004) 1.51
Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging (2011) 1.48
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 1.48
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. Eur J Nucl Med Mol Imaging (2011) 1.47
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? Endocrine (2013) 1.47
First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease. Eur J Nucl Med Mol Imaging (2015) 1.47
Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries. J Nucl Cardiol (2007) 1.42
Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. Eur J Nucl Med Mol Imaging (2007) 1.40
Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J Nucl Cardiol (2003) 1.40
Value of the single-phase technique in MDCT assessment of pancreatic tumors. AJR Am J Roentgenol (2005) 1.39
Long-Term Survival Benefit of Coronary Revascularization in Patients Undergoing Stress Myocardial Perfusion Imaging. Circ J (2015) 1.39
Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano (2012) 1.38
From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res (2010) 1.33
Synthesis, properties and perspectives of hybrid nanocrystal structures. Chem Soc Rev (2006) 1.28
Letter by Petretta and Cuocolo regarding article, "Four-variable risk model in men and women with heart failure". Circ Heart Fail (2014) 1.08
Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticles. Nano Lett (2013) 1.07
Prognosis in the era of comparative effectiveness research. J Nucl Cardiol (2013) 1.06
Optimal enhancement configuration of silica nanoparticles for ultrasound imaging and automatic detection at conventional diagnostic frequencies. Invest Radiol (2010) 1.05
One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals. J Am Chem Soc (2008) 1.05
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2007) 1.02
Fluorescent-magnetic hybrid nanostructures: preparation, properties, and applications in biology. IEEE Trans Nanobioscience (2007) 1.01
Characterization of a novel loss-of-function mutation of PAX8 associated with congenital hypothyroidism. Clin Endocrinol (Oxf) (2010) 0.96
Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol (2005) 0.95
Nanoparticles for imaging, sensing, and therapeutic intervention. ACS Nano (2014) 0.94
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. Thyroid (2008) 0.94
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure. J Am Heart Assoc (2013) 0.94
Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium. Eur J Nucl Med Mol Imaging (2004) 0.93
Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: synthesis and cancer cell targeting and sorting. ACS Nano (2011) 0.93
Plasmonic copper sulfide nanocrystals exhibiting near-infrared photothermal and photodynamic therapeutic effects. ACS Nano (2015) 0.93
Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano (2013) 0.92
CdSe/CdS/ZnS double shell nanorods with high photoluminescence efficiency and their exploitation as biolabeling probes. J Am Chem Soc (2009) 0.92
Copper sulfide nanocrystals with tunable composition by reduction of covellite nanocrystals with Cu+ ions. J Am Chem Soc (2013) 0.91
Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function. Eur J Nucl Med Mol Imaging (2012) 0.90
Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction. J Nucl Cardiol (2009) 0.90
Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches. Eur J Nucl Med Mol Imaging (2009) 0.89
Synthesis and biological assay of GSH functionalized fluorescent quantum dots for staining Hydra vulgaris. Bioconjug Chem (2007) 0.88
Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J Nucl Cardiol (2013) 0.88
Noninvasive assessment of coronary anatomy and myocardial perfusion: going toward an integrated imaging approach. J Cardiovasc Med (Hagerstown) (2008) 0.87
MRI characterization of myocardial tissue in patients with Fabry's disease. AJR Am J Roentgenol (2007) 0.87
Multifunctional nanostructures based on inorganic nanoparticles and oligothiophenes and their exploitation for cellular studies. J Am Chem Soc (2008) 0.87
The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ Cardiovasc Imaging (2013) 0.87
Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP. Nucl Med Biol (2013) 0.86
Fluorescent nanocrystals reveal regulated portals of entry into and between the cells of Hydra. PLoS One (2009) 0.86
Effects of exercise training started within 2 weeks after acute myocardial infarction on myocardial perfusion and left ventricular function: a gated SPECT imaging study. Eur J Prev Cardiol (2011) 0.86
Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers. J Nucl Cardiol (2008) 0.86
The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab (2002) 0.85
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care (2013) 0.85
Heat-generating iron oxide nanocubes: subtle "destructurators" of the tumoral microenvironment. ACS Nano (2014) 0.85
From Binary Cu2S to ternary Cu-In-S and quaternary Cu-In-Zn-S nanocrystals with tunable composition via partial cation exchange. ACS Nano (2015) 0.85
Prophylaxis of thromboembolism in bariatric surgery with parnaparin. Obes Surg (2007) 0.85
Impact of inducible ischemia by stress SPECT in cardiac risk assessment in diabetic patients: rationale and design of a prospective, multicenter trial. J Nucl Cardiol (2007) 0.85
Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging (2013) 0.84
Immunocytochemistry, electron tomography, and energy dispersive X-ray spectroscopy (EDXS) on cryosections of human cancer cells doped with stimuli responsive polymeric nanogels loaded with iron oxide nanoparticles. Methods Mol Biol (2013) 0.84
Magnetically triggered release of molecular cargo from iron oxide nanoparticle loaded microcapsules. Nanoscale (2015) 0.84
Water-repellent cellulose fiber networks with multifunctional properties. ACS Appl Mater Interfaces (2011) 0.84
Walk test at increased levels of heart rate in patients with dual-chamber pacemaker and with normal or depressed left ventricular function. Eur Heart J (2003) 0.84
Magnetic-fluorescent colloidal nanobeads: preparation and exploitation in cell separation experiments. Macromol Biosci (2009) 0.83
Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events. Am J Cardiol (2007) 0.83
Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis. Eur J Nucl Med Mol Imaging (2011) 0.82
Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab (2005) 0.82
The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab (2004) 0.82
Rod-shaped nanocrystals elicit neuronal activity in vivo. Small (2008) 0.82
Copper-triggered aggregation of ubiquitin. PLoS One (2009) 0.82
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Radiology (2010) 0.82
Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography. Eur J Nucl Med Mol Imaging (2009) 0.82
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity. Eur J Nucl Med Mol Imaging (2014) 0.82
Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis (2013) 0.81
Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Heart (2011) 0.81
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease. J Nucl Med (2005) 0.81
A cast-mold approach to iron oxide and Pt/iron oxide nanocontainers and nanoparticles with a reactive concave surface. J Am Chem Soc (2011) 0.81
Cardiovascular consequences of early-onset growth hormone excess. J Clin Endocrinol Metab (2002) 0.81
The "White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging": a message from the EANM and ESR Presidents. Eur J Nucl Med Mol Imaging (2007) 0.81
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction. Eur J Nucl Med Mol Imaging (2004) 0.80
The role of scintigraphic defecography in the assessment of bowel function after restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis (2006) 0.80
Mesoscale assemblies of iron oxide nanocubes as heat mediators and image contrast agents. Langmuir (2015) 0.80